Companies / Sana Biotechnology, Inc. / Activity
Activity — Sana Biotechnology, Inc.
28 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 9, 2026 | Harr Steve CEO | Other | Common Stock | $39.7K | -13K -0.16% | 7,944,251 2.65% of shares | low |
| Mar 9, 2026 | Harr Steve CEO | Other | Common Stock | $36.1K | -12K -0.14% | 7,957,070 2.66% of shares | low |
| Mar 9, 2026 | Wyrick Susan D. Executive | Other | Common Stock | $10.5K | -3K -1.67% | 197,241 0.07% of shares | low |
| Jan 5, 2026 | Wyrick Susan D. Executive | Other | Common Stock | $10.3K | -2K -1.28% | 185,883 0.06% of shares | low |
| Mar 9, 2026 | Wyrick Susan D. Executive | Other | Common Stock | $3.2K | -1K -0.53% | 196,196 0.07% of shares | low |
| Mar 3, 2026 | Wyrick Susan D. Executive | Other | Common Stock | $1.9K | -491 -0.26% | 186,917 0.06% of shares | low |
| Mar 7, 2026 | Harr Steve CEO | Exercise | Common Stock | $0 | +50K +0.63% | 7,968,596 2.66% of shares | low |
| Mar 6, 2026 | Harr Steve CEO | Exercise | Common Stock | $0 | +42K +0.53% | 7,918,596 2.65% of shares | low |
| Mar 7, 2026 | Wyrick Susan D. Executive | Exercise | Common Stock | $0 | +3K +1.65% | 200,583 0.07% of shares | low |
| Mar 6, 2026 | Wyrick Susan D. Executive | Exercise | Common Stock | $0 | +10K +5.57% | 197,333 0.07% of shares | low |
| Mar 2, 2026 | Wyrick Susan D. Executive | Exercise | Common Stock | $0 | +2K +0.82% | 187,408 0.06% of shares | low |
| Jan 2, 2026 | Wyrick Susan D. Executive | Exercise | Common Stock | $0 | +8K +4.15% | 188,290 0.06% of shares | low |
| Jan 5, 2026 | Bishop Hans Edgar Director | Grant | Common Stock | $0 | +6K +0.11% | 5,840,740 1.95% of shares | low |
| Jun 4, 2026 | Mulligan Richard Director | Grant | Stock Option (Right to Buy) | — | +90K | 90,000 0.03% of shares | low |
| Jun 4, 2026 | Yang Patrick Y Director | Grant | Stock Option (Right to Buy) | — | +90K | 90,000 0.03% of shares | low |
| Jun 4, 2026 | Nelsen Robert Director | Grant | Stock Option (Right to Buy) | — | +90K | 90,000 0.03% of shares | low |
| Mar 7, 2026 | Harr Steve CEO | Exercise | Restricted Stock Units | — | -50K -33.33% | 100,000 0.03% of shares | low |
| Mar 6, 2026 | Harr Steve CEO | Exercise | Restricted Stock Units | — | -42K -25.00% | 125,001 0.04% of shares | low |
| Mar 7, 2026 | Wyrick Susan D. Executive | Exercise | Restricted Stock Units | — | -3K -33.33% | 6,500 <0.01% of shares | low |
| Mar 6, 2026 | Wyrick Susan D. Executive | Exercise | Restricted Stock Units | — | -10K -25.00% | 31,251 0.01% of shares | low |
| Mar 5, 2026 | Harr Steve CEO | Grant | Stock Option (Right to Buy) | — | +900K | 900,000 0.30% of shares | low |
| Mar 5, 2026 | Harr Steve CEO | Grant | Restricted Stock Units | — | +200K | 200,000 0.07% of shares | low |
| Mar 5, 2026 | Wyrick Susan D. Executive | Grant | Stock Option (Right to Buy) | — | +206K | 206,250 0.07% of shares | low |
| Mar 5, 2026 | Wyrick Susan D. Executive | Grant | Restricted Stock Units | — | +46K | 45,833 0.02% of shares | low |
| Mar 2, 2026 | Wyrick Susan D. Executive | Exercise | Restricted Stock Units | — | -2K -50.00% | 1,525 <0.01% of shares | low |
| Feb 17, 2026 | Piper Brian Executive | Grant | Stock Option (Right to Buy) | — | +900K | 900,000 0.30% of shares | low |
| Feb 17, 2026 | Piper Brian Executive | Grant | Restricted Stock Units | — | +200K | 200,000 0.07% of shares | low |
| Jan 2, 2026 | Wyrick Susan D. Executive | Exercise | Restricted Stock Units | — | -8K -100.00% | 0 0.00% of shares | low |